Fig. 10
From: METTL7B is a novel prognostic biomarker of lower-grade glioma based on pan-cancer analysis
METTL7B alters the proliferation of LGG cells. A Colony formation experiments using HS683 and SHG44 showed reduced cell viability in the si-METTL7B group. B CCK-8 assays showed the suppressed proliferation ability of transfected LGG cells